
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Tech is well-positioned to continue its growth trajectory with expanding market opportunities and a strong pipeline. Tactile Systems Technology Inc's positive outlook can be attributed to its leadership in the lymphedema market, recent transformations and investments, and strategic collaborations and acquisitions. The company has seen faster growth and increased revenue guidance with the addition of LymphaTech and the growth of their respiratory product. Management is confident in achieving results and is focused on expanding sales and improving productivity. With a growing market and strong pipeline, Tactile Systems Tech is well-positioned to continue its positive growth trajectory.
Bears say
Tactile Systems Tech is facing various challenges that may hinder its growth potential, including potential disruptions in its lymphedema space and slower uptake in commercial channels. Furthermore, the company's increasing operating expenses and potential limitations on sales force leverage may impact its financial performance. With a significant portion of its revenue coming from Medicare, Tactile Systems Tech is also vulnerable to changes in government policies and reimbursement processes. As such, a negative outlook on the stock may be warranted due to these fundamental risks.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares